Showing results (51-60 of 123) with videos related to

Sort By:
Pageof 13
Neoplasia (New York, N.Y.)|October 13, 2006
Overexpression of PIAS3 suppresses cell growth and restores the drug sensitivity of human lung cancer cells in association with PI3-K/Akt inactivationYoshitaka Ogata, Tadashi Osaki, Tetsuji Naka, et al.
Internal Medicine (Tokyo, Japan)|March 14, 2022
Sinus Node Dysfunction Co-occurring with Immune Checkpoint Inhibitor-associated MyocarditisTatsuya Nishikawa, Kei Kunimasa, Keiko Ohta-Ogo, et al.
Molecular and Clinical Oncology|August 17, 2017
Impact of in vitro chemosensitivity test-guided platinum-based adjuvant chemotherapy on the surgical outcomes of patients with p-stage IIIA non-small cell lung cancer that underwent complete resectionYuki Akazawa, Masahiko Higashiyama, Kazumi Nishino, et al.
Human Pathology|January 8, 2026
Targeted RNA sequencing enhances the integrated diagnosis of bone and soft tissue tumorsHarumi Nakamura, Yoji Kukita, Toru Wakamatsu, et al.
Biochemical and Biophysical Research Communications|February 22, 2005
Cigarette smoke extract induces endothelial cell injury via JNK pathwayShigenori Hoshino, Mitsuhiro Yoshida, Koji Inoue, et al.
Cancer Research|October 5, 2006
Absence of CD9 enhances adhesion-dependent morphologic differentiation, survival, and matrix metalloproteinase-2 production in small cell lung cancer cellsYoshiyuki Saito, Isao Tachibana, Yoshito Takeda, et al.
Neuro-Oncology Advances|July 10, 2020
The impact of EGFR mutation status and single brain metastasis on the survival of non-small-cell lung cancer patients with brain metastasesYuya Fujita, Manabu Kinoshita, Tomohiko Ozaki, et al.
Thoracic Cancer|October 30, 2020
Effectiveness of EGFR tyrosine kinase inhibitors in advanced non-small cell lung cancer patients with uncommon EGFR mutations: A multicenter observational studyMasaki Kanazu, Masahide Mori, Madoka Kimura, et al.
Investigational New Drugs|June 28, 2018
Proliferative CD8(+) PD-1(+) T-cell infiltration in a pembrolizumab-induced cutaneous adverse reactionKei Kunimasa, Taiki Isei, Harumi Nakamura, et al.
Lung Cancer (Amsterdam, Netherlands)|May 18, 2019
Patients with SMARCA4-deficient thoracic sarcoma and severe skeletal-related eventsKei Kunimasa, Harumi Nakamura, Kazuko Sakai, et al.
Pageof 13